1. Home
  2. MNMD vs GLDD Comparison

MNMD vs GLDD Comparison

Compare MNMD & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • GLDD
  • Stock Information
  • Founded
  • MNMD 2019
  • GLDD 1890
  • Country
  • MNMD United States
  • GLDD United States
  • Employees
  • MNMD N/A
  • GLDD N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • GLDD Military/Government/Technical
  • Sector
  • MNMD Health Care
  • GLDD Industrials
  • Exchange
  • MNMD Nasdaq
  • GLDD Nasdaq
  • Market Cap
  • MNMD 811.9M
  • GLDD 813.2M
  • IPO Year
  • MNMD N/A
  • GLDD 2006
  • Fundamental
  • Price
  • MNMD $12.51
  • GLDD $11.62
  • Analyst Decision
  • MNMD Strong Buy
  • GLDD
  • Analyst Count
  • MNMD 6
  • GLDD 0
  • Target Price
  • MNMD $26.50
  • GLDD N/A
  • AVG Volume (30 Days)
  • MNMD 1.8M
  • GLDD 436.7K
  • Earning Date
  • MNMD 11-06-2025
  • GLDD 11-04-2025
  • Dividend Yield
  • MNMD N/A
  • GLDD N/A
  • EPS Growth
  • MNMD N/A
  • GLDD 63.54
  • EPS
  • MNMD N/A
  • GLDD 1.06
  • Revenue
  • MNMD N/A
  • GLDD $830,567,000.00
  • Revenue This Year
  • MNMD N/A
  • GLDD $13.73
  • Revenue Next Year
  • MNMD N/A
  • GLDD $3.56
  • P/E Ratio
  • MNMD N/A
  • GLDD $11.24
  • Revenue Growth
  • MNMD N/A
  • GLDD 24.40
  • 52 Week Low
  • MNMD $4.70
  • GLDD $7.51
  • 52 Week High
  • MNMD $12.94
  • GLDD $12.89
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 66.16
  • GLDD 44.44
  • Support Level
  • MNMD $11.81
  • GLDD $11.56
  • Resistance Level
  • MNMD $12.94
  • GLDD $12.14
  • Average True Range (ATR)
  • MNMD 0.86
  • GLDD 0.28
  • MACD
  • MNMD 0.17
  • GLDD -0.05
  • Stochastic Oscillator
  • MNMD 88.48
  • GLDD 8.13

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: